Anti-snoring devices encompass a broad range of products designed to mitigate or eliminate snoring and improve sleep quality, including mandibular advancement devices (MADs), nasal dilators, tongue stabilizing devices, CPAP mask accessories, and adjustable chin straps. These solutions offer non‐invasive alternatives to surgery, promoting patient comfort, ease of use, and rapid deployment in home environments.

 Advances in biocompatible materials, 3D printing, and customized fittings ensure better patient compliance and fewer side effects such as jaw discomfort. As sleep disorders escalate worldwide, anti-snoring devices play a crucial role in reducing daytime fatigue, cardiovascular risks, and impaired cognitive function linked to chronic sleep disturbance. Growing awareness among consumers and healthcare professionals about the health risks of untreated snoring and obstructive sleep apnea has spurred demand for reliable, user-friendly products.

According to CoherentMI, The anti-snoring devices market is estimated to be valued at USD 1.72 Bn in 2025 and is expected to reach USD 2.82 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.


Key Takeaways



• Key Players

Key players operating in the Anti-Snoring Devices Market are ResMed, Koninklijke Philips NV, SomnoMed, Fisher & Paykel Healthcare Limited, GSK plc. These companies hold strong portfolios of mandibular advancement devices, nasal breathing aids, and sleep tracking accessories. ResMed focuses on integrated sleep solutions, combining CPAP devices with smart mask designs to enhance comfort. Koninklijke Philips NV leverages its broad respiratory care division to introduce connected anti-snoring kits that sync with mobile applications for real‐time monitoring.

 SomnoMed specializes in custom-fitted oral devices, utilizing digital scanning technologies to reduce lead times. Fisher & Paykel Healthcare Limited emphasizes user-centric mask interface innovations, while GSK plc explores advanced pharmaceutical adjuncts that complement mechanical anti-snoring aids. Collectively, these players invest heavily in R&D, strategic acquisitions, and partnerships to expand product lines and address diverse patient needs.



• Key Opportunities

The anti-snoring devices market presents significant opportunities driven by emerging personalized healthcare and remote patient monitoring. Integration of wearable sleep trackers and mobile apps enables manufacturers to offer bundled solutions—combining hardware and software—to improve compliance and outcomes. The aging global population, with a higher prevalence of sleep-disordered breathing, represents a growing consumer base seeking non‐invasive interventions. Telemedicine adoption further expands access, allowing physicians to prescribe and adjust devices remotely. Additionally, rising disposable incomes and increased health awareness in developing regions open new distribution channels. R&D into novel materials, such as memory foam conformers and antimicrobial coatings, can differentiate products and address hygiene concerns, bolstering market penetration.



• Global Expansion

Regional expansion is a key growth strategy, as demand in North America and Western Europe matures. Manufacturers are targeting high‐growth markets in Asia Pacific, Latin America, and the Middle East by forming strategic alliances with local distributors and clinics. Regulatory approvals by bodies such as the US FDA and European CE mark pave the way for market entry, while partnerships with sleep centers and dental networks help build trust. Local manufacturing initiatives reduce production costs and allow price adjustments to meet regional purchasing power. Collaborative campaigns with public health agencies to raise awareness about sleep apnea drive consumer education and device adoption across emerging economies.



Market Drivers

A primary driver of the Anti-Snoring Devices Market is the rising prevalence of obstructive sleep apnea (OSA) and growing awareness of its serious health implications. According to epidemiological data, OSA affects an estimated 25% of adults globally, with many remaining undiagnosed due to limited access to sleep studies. Increased screening efforts by healthcare providers, coupled with digital health platforms offering at‐home diagnostic tools, are bridging this gap. As patients and clinicians recognize the link between untreated snoring, cardiovascular disease, and metabolic disorders, demand for effective, patient‐friendly anti-snoring solutions intensifies. Technological advancements—such as adjustable mandibular advancement devices that can be fine‐tuned remotely—enhance treatment efficacy and user compliance. Furthermore, public health campaigns emphasizing the importance of quality sleep have fostered a proactive consumer mindset, driving growth across both prescription- and over‐the-counter product segments.



Market Restraint

A significant restraint in the Anti-Snoring Devices Market lies in the high cost of premium solutions and inconsistent reimbursement policies across regions. Advanced mandibular advancement devices and smart CPAP mask systems often require custom fittings, specialized materials, and ongoing maintenance, resulting in price tags that can exceed US$ 500 per unit. This upfront expense deters price‐sensitive patients, particularly in markets where health insurance does not cover anti-snoring devices or where reimbursement guidelines are unclear. Additionally, variability in coverage between private insurers and public health schemes leads to disparities in patient access. Poor adherence stemming from discomfort, device maintenance requirements, and perceived complexity further undermines market uptake. Manufacturers must contend with balancing innovation-driven cost structures against the need for broader affordability and clearer insurance pathways to sustain long‐term growth.


Segment Analysis

The Anti-Snoring Devices Market can be segmented by device type, with the primary categories being mandibular advancement devices (MADs), tongue stabilizing devices (TSDs), and nasal dilators. Among these, mandibular advancement devices represent the dominating sub-segment. MADs work by gently repositioning the lower jaw forward, thereby enlarging the upper airway and reducing soft tissue vibration during sleep.

Their dominance stems from a combination of high clinical efficacy, strong dentist and sleep specialist endorsement, and a wide range of customization options. Custom-fit MADs in particular command the largest share within this sub-segment, as they are individually molded to a patient's dentition, offering superior comfort and compliance compared to boil-and-bite alternatives. This customization reduces the need for repeated adjustments, which can be a drawback of prefabricated products. Additionally, ongoing technological improvements, such as 3D scanning and digital manufacturing, have lowered production lead times and enhanced fit accuracy, further bolstering the appeal of custom MADs. Meanwhile, tongue stabilizing devices and nasal dilators continue to attract niche user groups—those who cannot tolerate jaw repositioning or who experience snoring primarily due to nasal congestion—but they remain secondary to the broader MAD segment.



Global Analysis

Regionally, North America currently dominates the Anti-Snoring Devices Market, driven by high awareness of sleep-related breathing disorders, established reimbursement frameworks, and widespread adoption of home sleep testing. The presence of leading manufacturers, partnerships with dental clinics, and ongoing physician education programs have created a robust ecosystem that favors early uptake of advanced anti-snoring solutions.

 Europe follows closely, supported by similar healthcare infrastructure and growing patient outreach initiatives in countries such as Germany, the U.K., and France. In contrast, the fastest‐growing region is Asia-Pacific. Rising healthcare spending, growing urban populations grappling with lifestyle-related snoring issues, and expanding distribution networks are fueling rapid market acceleration in China, India, Japan, and Australia. Local manufacturers are increasingly partnering with global players to introduce cost-competitive, regionally tailored products. Moreover, government initiatives aimed at increasing sleep health awareness, combined with a swelling middle-class with greater disposable income, are augmenting device penetration. Latin America and the Middle East & Africa are emerging as promising secondary markets, with incremental growth expected as patient education and supplier reach continue to improve.

Get more insights on: Anti-Snoring Devices Market

Get this Report in Japanese Language: 코골이방지장치시장

  

Get this Report in Korean Language: いびき防止装置市場

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)